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We have defined the molecular basis for association
of the PH domain of the Arf GAP ASAP1 with phos-
pholipid bilayers. Structuresof theunligandedanddi-
butyryl PtdIns(4,5)P2-bound PH domain were solved.
PtdIns(4,5)P2made contactwith both a canonical site
(C site) and an atypical site (A site). We hypothesized
cooperative binding of PtdIns(4,5)P2 to the C site
and a nonspecific anionic phospholipid to the A site.
PtdIns(4,5)P2 dependence of binding to large unila-
mellar vesicles and GAP activity was sigmoidal, con-
sistent with cooperative sites. In contrast, PtdIns(4,5)
P2 binding to the PH domain of PLC d1was hyperbol-
ic. Mutation of amino acids in either the C or A site re-
sulted indecreasedPtdIns(4,5)P2-dependentbinding
to vesicles and decreased GAP activity. The results
support the idea of cooperative phospholipid binding
to the C and A sites of the PH domain of ASAP1. We
propose that the mechanism underlies rapid switch-
ing between active and inactive ASAP1.INTRODUCTION
PH domains are regulatory components of hundreds of hu-
man proteins involved in signaling, membrane traffic, and
actin cytoskeleton remodeling (DiNitto and Lambright, 2006;
Lemmon, 2008; Lemmon et al., 1996; Moravcevic et al.,
2012). The domain is defined structurally as a sandwich of
seven b strands capped at one end by an a helix. A subset
of PH domains binds to phosphoinositides and proteins.
Several mechanisms by which ligand binding to PH domains
regulates protein activity have been proposed, but the kinetic
and molecular basis for rapid switching between the ligandStructure 23, 1977–19bound and unliganded forms of PH domains has not been
explored.
Amajor functionofPHdomains is to localizeproteins tospecific
membrane regions through binding to specific phosphoinositides
(Moravcevic et al., 2012). For example, proteins containing phos-
phatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3)-binding PH
domains are recruited to membranes in which PtdIns(3,4,5)P3 is
produced. Membrane localization may be further specified by
the coincidence of two signals, which was first described for
two independent domains within a single protein, each domain
having distinct ligand specificities (Moravcevic et al., 2012). Coin-
cidence detection may also be mediated by a single PH domain
binding two distinct ligands (Balla, 2005), as recently described
for FAPP1, which simultaneously binds phosphoinositides and
Arf1-GTP (Godi et al., 2004; He et al., 2011; Liu et al., 2014) and
Grp1, which simultaneously binds PtdIns(3,4,5)P3 and Arf6-GTP
(DiNitto et al., 2007; Malaby et al., 2013). The two ligands can
also be different lipids, as seen with the yeast Slm1p PH domain
(Gallego et al., 2010).
PH domains can function in capacities other than localization
signals (DiNitto and Lambright, 2006). For example, in some Dbl-
family Rho GTPase exchange factors (Rho GEFs), PH domains
can form part of the substrate-binding site (Rossman et al.,
2002) and, in other Rho GEFs, occlude the enzymatic site (He
et al., 2013). PH domains of cytohesin family Arf guanine nucle-
otide exchange factors (Arf GEFs) position autoinhibitory motifs
that are displaced on binding to Arf6-GTP (DiNitto et al., 2007;
Malaby et al., 2013). In Akt the PH domain inhibits the associated
catalytic domain, a serine/threonine kinase (Alessi et al., 1997;
Chan et al., 1999; Milburn et al., 2003; Thomas et al., 2002).
Whether through localization or direct effects on catalytic
sites, PH domain function in cellular signaling can be expected
to involve rapid and complete switching between states. G pro-
teins are another example of a protein motif used in signaling
(Sprang, 1997; Vetter and Wittinghofer, 2001; Wittinghofer and
Vetter, 2011). G proteins achieve rapid state transitions, ne-
cessary for function as molecular switches, through a cycle of88, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1977
binding and hydrolysis of GTP. PH domains, in contrast, do not
have a catalytic function and depend on binding and dissociation
of activating ligands.
Rapid and efficient switching driven by ligand binding and
dissociation may be achieved by cooperativity. We propose
that cooperative binding to two lipid ligands may be a function
of a subset of PH domains. Indeed, two distinct lipid-binding
sites have been described in PH domains: a canonical site be-
tween the b1/b2, b3/b4, and b6/b7 loops, and an ‘‘atypical’’ bind-
ing site on the opposite side of the b1/b2 loop, adjacent to the b5/
b6 loop (Balla, 2005; DiNitto and Lambright, 2006; Moravcevic
et al., 2012). The now atypical site was actually seen first in the
structure of the Ins(1,4,5)P3-bound spectrin-b2 PH domain (Hy-
vonen et al., 1995), and has also been observed in Tiam1 and
ArhGAP9 PH domains (Ceccarelli et al., 2007). Although in
most cases examined only the canonical or non-canonical site
is occupied, cooperative binding to both sites has been pro-
posed for the PH domain of the yeast protein Slm1 (Anand
et al., 2012; Gallego et al., 2010). Furthermore, biochemical evi-
dence supports the existence of two lipid-binding sites in two
other PH domains, those of Akt (Huang et al., 2011) and
ASAP1 (Kam et al., 2000).
In the current study, we used the PHdomain of ASAP1 to study
the mechanism of cooperative lipid binding to two sites in a sin-
gle PH domain (Brown et al., 1998; Che et al., 2005; Kam et al.,
2000; Luo et al., 2008). ASAP1 is an Arf GTPase-activating pro-
tein (Arf GAP) that catalyzes the conversion of Arf-GTP to Arf-
GDP by inducing the hydrolysis of GTP. ASAP1 is structurally
complex, containing BAR, PH, Arf GAP, Ank repeat, Proline-
rich, and SH3 domains. The SH3 and Proline-rich domains
mediate targeting of ASAP1 to specific cellular sites by pro-
tein-protein interaction (Liu et al., 2002; Oda et al., 2003). The
PH domain does not drive localization, but is nevertheless crucial
for ASAP1 regulation. Phosphatidylinositol 4,5-bisphosphate
(PtdIns(4,5)P2) binds to the PH domain to increase enzymatic ac-
tivity approximately 10,000-fold (Kam et al., 2000). Two cooper-
ative lipid-binding sites have been biochemically defined for the
ASAP1 PH domain. Mutagenesis was previously used to tenta-
tively identify a canonical PtdIns(4,5)P2-binding site (Kam et al.,
2000), but neither lipid-binding site has been unambiguously
identified at atomic resolution, nor has the physical basis of
apparent cooperativity been determined.
Here, we have solved the crystal structures of the unliganded
PH domain of ASAP1 and the PH domain with dibutyryl
PtdIns(4,5)P2 bound. The structures form the basis of our hy-
pothesis of cooperative binding to canonical (C) and atypical
(A) sites in the PH domain. Nuclear magnetic resonance (NMR)
and mutagenesis results supported PtdIns(4,5)P2 binding to
the C and A sites. We speculate that cooperativity enables rapid
and reversible activation of ASAP1 through ligand binding and
dissociation.
RESULTS
Structures of Unliganded and Dibutyryl PtdIns(4,5)P2-
Bound ASAP1 PH Domain
We determined the structure of the PH domain (residues G325–
D451 of ASAP1, Figure 1A) by X-ray crystallography. Crystals of
purified ASAP1 PH domain were obtained and diffracted X-rays1978 Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltdto 1.78 A˚ resolution using a synchrotron radiation source. The
structure was determined by molecular replacement using the
coordinates (PDB: 2DA0) from NMR studies and refined with a
final Rwork and Rfree of 0.23 and 0.29, respectively (Table 1).
The ASAP1 PH domain displays a ‘‘stripped-down,’’ canonical
PH domain fold of seven-stranded b sandwich consisting of
N-terminal four-stranded (b1-b4) and C-terminal three-stranded
(b5-b7) b sheets, and is terminated with a long a helix wedged
between the two sheets of the b sandwich at one end (Figures
1B and 1C). Three of the loops connecting b strands are disor-
dered in the unliganded structure, the b1/b2, b3/b4, and b5/b6
loops. Like other phospholipid-binding PH domains, the surface
charge distribution is polarized (Figure 1D), consistent with its
proposed function of membrane bilayer interaction. Strong, pyr-
amid-shaped electron density was found in a surface cavity sur-
rounded by positively charged residues from b1/b2, b3/b4, and
b6/b7 loops, which corresponds to the canonical phosphoinosi-
tide (PtdIns)-binding site. Since sodium phosphate is present
in the crystallization conditions, this density likely represents a
phosphate molecule occupying the C site.
We also prepared the complex between ASAP1 PH domain
and dibutyryl PtdIns(4,5)P2 (ASAP1 PH domain/diC4-PtdIns(4,5)
P2) by incubating the two components in a molar ratio of 1:2.5.
Crystals of ASAP1 PH domain/diC4-PtdIns(4,5)P2 complex dif-
fracted X-rays to 1.6 A˚ resolution using an in-house X-ray source
(Table 1). The structure was again determined by molecular
replacement, using the coordinates of the unliganded ASAP1
PHdomain as a startingmodel, andwas refined toRwork andRfree
values of 0.20 and 0.24, respectively.
In the ASAP1 PH domain/diC4- PtdIns(4,5)P2 complex crystal,
there are two ASAP1 PH domain molecules (A and B) in a crys-
tallographic asymmetric unit. Among the ways of selecting
two monomers to form the asymmetric unit, one dimer pair is
interesting due to its polarized surface charges and binding po-
sitions of the ligand (Figure 1E). The difference Fourier map
showed a large peak of electron density in each of the canonical
PtdIns(4,5)P2 binding sites, which matched the shape of the
head group of diC4-PtdIns(4,5)P2. In addition, a large electron
density peak was seen at the A site, present at the interface
formed between the two monomers in the crystallographic
asymmetric unit, which fits a diC4-PtdIns(4,5)P2 moiety (Fig-
ure 1E). This bound diC4-PtdIns(4,5)P2 is more ordered than
those found in the canonical sites, and its chemical identity
was verified by the presence of anomalous peaks for all three
phosphate groups (Figure S1A), compared with the bound
diC4-PtdIns(4,5)P2 at the C site that have weaker anomalous dif-
ference Fourier density (Figure S1B). Among the five residues
that participate in interacting with this ligand, four come from
molecule B (Q412, K349, K355, and W357), and are residues in
the A site. NMR chemical-shift studies also argued that
PtdIns(4,5)P2 interacts with both the C site and the A site in solu-
tion. In 15N heteronuclear single-quantum coherence experi-
ments (Figure S1C), PtdIns(4,5)P2 titration resulted in chemical-
shift perturbations for K349 and W357 in the A site and K348,
R360, R378, and R407 in the C site, thus establishing that the in-
teractions are not the result of crystal packing effects.
We found that the binding orientation of diC4-PtdIns(4,5)P2 in
the C site of one molecule is different from that in the other, with
the inositol ring flipped 180 (Figures S2A and S2B), although inAll rights reserved
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Figure 1. Structures of Unliganded PH Domain of ASAP1 and Its Complex with diC4-PtdIns(4,5)P2
(A) Schematic representation of proteins used in this study.
(B) Ribbon representation of the structure of monomeric unliganded ASAP1 PH domain. Both N and C termini are labeled along with all b strands, as well as loops
linking the b strands. The putative phosphate group is shown as a ball model with the phosphorus atom in orange and oxygen atoms in red. Residues that are
interacting with the phosphate group are shown as stick models.
(C) Sequence of the ASAP1 PH domain aligned with other PH domains. Assignment of secondary structural elements defined by the crystal structure is shown.
ASAP1, GI j4063616; ASAP2, GI j48474259; ASAP3, GI j221307473; ACAP1, GI j7661880; ACAP2, GI j39932727; PLCd1, GI j130228.
(D) Electrostatic potential of monomeric ASAP1 PH domain. The surface representation of the electrostatic potential is superimposed on the ribbon structure of
the ASAP1 PH domain. The phosphate group is shown as a ball model.
(E) One possible dimeric association of the two ASAP1 PH domains (A and B) in crystal. Ribbon representation of two molecules (A in coral and B in purple) in the
asymmetric unit is shown. The two different PtdIns(4,5)P2 binding sites are illustrated as A site formed at the dimer interface and C site formed between b1/b2 and
b3/b4 loops.
See also Figures S1, S2 and S3.
Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1979
Table 1. Statistics on Qualities of X-Ray Diffraction Datasets and
Atomic Models
ASAP1 PH
Domain
ASAP1 PH
Domain:diC4-
PtdIns(4,5)P2
Diffraction Datasets
X-Ray wavelength (A˚) 1.0 1.54
Space group P43 P21
Cell dimensions (A˚, ) a = b = 48.12,
c = 111.33
a = 37.54, b = 64.70,
c = 44.43, b = 95.63
Resolution (A˚) 50–1.80 (1.86–1.80)a 50–1.60 (1.66–1.60)
Merging R factors 0.099 (0.515) 0.075 (0.481)
Completeness (%) 95.4 (75.9) 97.6 (82.9)
No. of unique reflections 22,383 27,403
Redundancy 4.6 (1.9) (3.2) 1.9
I/sI 15.6 (1.35) 15.3 (1.1)
Model Refinement
Resolution refined (A˚) 20–1.81 27–1.60
Rwork 0.21 (0.346) 0.20 (0.474)
Rfree 0.26 (0.376) 0.23 (0.486)
No. of molecules/AU 2 2
No. of ligands/AU 2 PO4
3 3 diC4-PtdIns(4,5)P2
No. of protein atoms 1,765 1,667
No. of solvent molecules 34 222
No. of polymers 3 –
Ramachandran plot (%)
Preferred 98.12 97.04
Allowed 0.47 2.96
Outlier 1.41b 0
PDB 5C6R 5C79
aNumbers in parentheses are for the outermost-resolution shell.
bOutliers are located in the disordered regions.both binding modes the same set of residues are employed for
interactions. Consequently, residues in the two binding sites
adopt slightly different conformations that best fit the bound
ligand. This is not surprising because most of the protein-ligand
binding energy appears to be derived from charge-charge inter-
actions involving the two phosphate groups at the 4- and 5-po-
sitions. Indeed, the phosphates at 4- and 5-positions are super-
imposable when molecule A is brought into alignment with B
(Figure S3A).
Cooperative Dual Lipid-Binding-Dependent Membrane
Bilayer Attachment and ASAP1 Activation
Based on the observed electron density, both 2Fo-Fc and anom-
alousdifferenceFouriermaps (FigureS1), and the thermo-motion
factor for bound ligands, the PtdIns(4,5)P2 bound at the A site is
more ordered than that bound at the C site, suggesting the pos-
sibility of stronger binding of PtdIns(4,5)P2 at the A site, which
may in turn suggest that this is the first binding site to beoccupied
when theASAP1PHdomain binds tomembranes. In the absence
of the ligand,b1/b2,b3/b4, andb5/b6 loops aredisordered.When
the unliganded ASAP1 PH domain structure is aligned with the
PtdIns(4,5)P2-bound structure (Figure 2A), several conforma-1980 Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltdtional changes are observed. (1) As expected upon ligand bind-
ing, the disordered loops, including the b1/b2 and b3/b4 loops,
become better ordered; this transition is especially true for the
b1/b2 loop that is sandwiched between the two lipid-binding
sites. The lowered mobility for the b1/b2 and b3/b4 loops is to
be expected, as both loops contribute to the formation of the A
and C sites. (2) Binding of diC4-PtdIns(4,5)P2 alters the structure
of ASAP1 PH domain locally, concentrating predominantly in the
canonical phosphoinositide-binding site, inducing an outward
movement of the b1/b2 and b3/b4 loop and thus a small expan-
sion of the binding site compared with the unliganded ASAP1
PH domain (Figure 2A). (3) Binding of PtdIns(4,5)P2 also moves
the second b sheet (made of b strands 5, 6, and 7) toward the C
site (Figure 2A). Based on the identification of two inositol contact
sites in the diC4-PtdIns(1,4,5)P3 crystal, we propose that the lipid
bilayer-binding interface of the PH domain involves cooperation
between the canonical phosphoinositide-binding site and the
atypical phospholipid-binding site. We also propose, based on
previous biochemical studies, that the atypical site can accom-
modate anionic phospholipid head groups, with little specificity
for particular head groups. A representation of the hypothesis is
schematized in Figure 2C. The atypical site is represented by
an ‘‘A’’ and the canonical site by a ‘‘C’’ in the diagram. Binding
is cooperative, and occupancy of both sites increasesGAPactiv-
ity. The active form of the enzyme is indicated by an asterisk. If
binding is cooperative as proposed, forms 1, 2, and 3 are the pri-
mary species present at equilibrium.
The hypothesis diagrammed in Figure 2 predicts that the
PtdIns(4,5)P2 dependence, in the absence of other anionic lipids
that might occupy the A site, is sigmoidal for both binding and
activity (for equations, see Experimental Procedures). We
titrated PtdIns(4,5)P2 in large unilamellar vesicles (LUVs) and
measured binding of the isolated PH domain to the LUVs. As
predicted, PtdIns(4,5)P2-dependent binding of the PH domain
of ASAP1 to LUVs was sigmoidal (Figure 3A1). We propose
that there are two sites, one that can accommodate any anionic
phospholipid, including phosphatidylserine (PtdSer), and one
specific for PtdIns(4,5)P2. With the second site occupied by
PtdSer (with 15% PtdSer), the PtdIns(4,5)P2 dependence of
binding is predicted to be hyperbolic, which was indeed
observed (Figure 3A1). Results with a fragment of ASAP1 com-
prising the PH, Arf GAP, and Ankyrin repeat domains (henceforth
called PZA), which hasArf GAP activity, were similar (Figure 3A3),
with a sigmoidal PtdIns(4,5)P2 dependence for binding in the
absence of PtdSer and a hyperbolic dependence in the presence
of PtdSer. A recombinant protein comprising the PH domain of
PLCd1 either as an isolated protein or fused to the Arf GAP
and Ank repeat domains of ASAP1 (henceforth called PdZA)
had neither the sigmoidal PtdIns(4,5)P2 dependence for binding
nor an effect of PtdSer (Figures 3A2 and A4, Table 2), and the
PLCd PH domain binds with significantly higher affinity. Thus,
the sigmoidal PtdIns(4,5)P2-binding behavior was specific for
the PH domain of ASAP1.
GAP activity of ASAP1 was similarly dependent on anionic
phospholipids (Figure 3B). In the absence of a second anionic
phospholipid, the PtdIns(4,5)P2 dependence of GAP activity
was sigmoidal. In the presence of PtdSer, the PtdIns(4,5)P2
dependence was shifted from a half-maximal effect seen at
18 to 8 mM and was hyperbolic (Figure 3B).All rights reserved
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Figure 2. Hypothesized Two Lipid-Binding
Sites
(A) Superposition of the structure of the unliganded
ASAP1 PH domain with that bound with diC4-
PtdIns(4,5)P2. The unliganded structure is in gray
and the complex is shown in purple. The A- and C-
site occupants are shown in the ball-and-stick
models with carbon in black, phosphor in orange,
and oxygen in red. Loops that show large confor-
mational changes are labeled.
(B) Two lipid-binding sitesmodel. The A site, C site,
and the ordering of the b1/b2 basic loop upon
simultaneous occupation of both A and C sites by
lipids is shown. The ASAP1 PH domain is shown as
transparent electrostatic potential surface with
both sites taken by bound lipids.
(C) Schematic of interaction of two lipid-binding
sites. Twobinding sites are depicted. TheA site can
be occupied by any anionic phospholipid. The C
site is specific for phosphoinositides. K1,PtdIns(4,5)P2
is the dissociation constant of PtdIns(4,5)P2 in the
atypical site. K1,PtdSer is the dissociation constant
for PtdSer in the atypical site. K2 is the dissociation
constant for PtdIns(4,5)P2 binding to the canonical
site. a is the interaction factor.In our hypothesis, GAP activity depends on two sites in the PH
domain being occupied, with one site specific for PtdIns(4,5)P2
(Figure 2C). A prediction of the model is that saturating
PtdIns(4,5)P2 (50 mM), or PtdIns(4,5)P2 together with PtdSer,
should support similar levels of GAP activity, whereas ASAP1
would have less activity in the absence of PtdIns(4,5)P2 (since
the canonical site is not occupied). To test this prediction,
ASAP1 was titrated into reactions containing either no anionic
phospholipid, PtdSer, PtdIns(4,5)P2, or PtdSer plus PtdIns(4,5)
P2 (Figure 3C and Table 3). The amount of ASAP1 necessary to
hydrolyze 50% of the GTP bound to Arf in the reaction (C50)
was estimated. In the absence of anionic phospholipid, 1 mM
ASAP1 was required. The presence of PtdSer increased activity
by 15-fold. In contrast, PtdIns(4,5)P2 alone or PtdSer plus
PtdIns(4,5)P2 increased activity approximately 20,000-fold
compared with no anionic lipid and 1,500-fold compared with
PtdSer alone. These data are similar to those previously obtained
in the context of Triton X-100 mixed micelles (Kam et al., 2000)
which, together with the comparison with the PLC d1 PHdomain,Structure 23, 1977–1988, November 3, 2015suggest that the differences are not the
result of changes in lipid presentation,
but rather are a consequence of two
distinct contact surfaces for lipid head
groups on the PH domain of ASAP1.
Our hypothetical binding mechanism
also predicts that inositol 1,4,5-trisphos-
phate (Ins(1,4,5)P3), the head group of
PtdIns(4,5)P2 that binds to the C site,
should have lower affinity for the ASAP1
PH domain than does PtdIns(4,5)P2 in a
bilayer containing PtdSer. The opposite
has been reported for the PH domain of
PLCd1; the head group has higher affinity
than does the lipid in a bilayer (Lemmonet al., 1995). We tested the prediction in three ways. First, we
determined binding of Ins(1,4,5)P3 to the PH domain of ASAP1
and the PH domain of PLCd1 by isothermal titration calorimetry
(ITC) (Figure 4A1 and A2). We could not detect saturable binding
for ASAP1; the dissociation constant (KD) was 100 mM or greater
for Ins(1,4,5)P3, compared with 7 ± 1 mM (mean ± SEM, n = 6) for
PtdIns(4,5)P2 in an LUV. The KD for Ins(1,4,5)P3 binding to the
PLCd1 PH domain, by contrast, was 0.18 ± 0.03 mM, compared
with a KD of 1.7 ± 0.2 mM for PtdIns(4,5)P2 in an LUV, consistent
with previous findings (Lemmon et al., 1995). We had previously
found that binding of soluble analogs of PtdIns(4,5)P2 to the
ASAP1 PH domain results in a change in tryptophan fluores-
cence. The effect of diC4-PtdIns(4,5)P2 was saturable with a
half-maximal effect at 120 mM (Figure 4B). The third test of the
prediction was to displace ASAP1 and PLCd1 PH domains
from PtdIns(4,5)P2 containing LUVs with Ins(1,4,5)P3 (Fig-
ure 4C1–4). The amount of Ins(1,4,5)P3, relative to PtdIns(4,5)
P2, required to displace the PH domain is a measure of relative
affinity of the PH domain for Ins(1,4,5)P3 and PtdIns(4,5)P2. Toª2015 Elsevier Ltd All rights reserved 1981
Figure 3. Anionic Phospholipid Depen-
dence of ASAP1 and PLC d1 PH Domain
Binding to Lipid Vesicles and ASAP1 GAP
Activity
(A) PtdSer and PtdIns(4,5)P2 dependence for
binding of ASAP1 and PLC d1 PH domains to
phospholipid vesicles. (1) Isolated PH domain of
ASAP, (2) isolated PH domain of PLC d1, (3) PZA
(PH-ArfGAP-Ank repeats of ASAP1), and (4) PdZA
(PH domain of PLC d1 fused to the Arf GAP and
Ank repeats of ASAP1) were incubated with large
unilamellar vesicles (LUVs) containing the indi-
cated concentration of PtdSer and PtdIns(4,5)P2.
Protein binding to the LUVs was determined as
described in Experimental Procedures.
(B) PtdSer and PtdIns(4,5)P2 dependence of GAP
activity in PZA. GAP activity using myrArf1$GTP as
a substrate was estimated for PZA incubated with
LUVs containing 15% PtdSer and PtdIns(4,5)P2 as
indicated.
(C) Effect of PtdSer and PtdIns(4,5)P2 on the rela-
tive activity of PZA. PZAwas titrated into a reaction
containing myrArf1$GTP as a substrate and LUVs
containing 15% PtdSer, 10% PtdIns(4,5)P2, or
both as indicated. The percentage of the GTP
bound to Arf that was hydrolyzed in 3min is plotted
against PZA concentration. The data are one of
three experiments used to estimate the concen-
tration of PZA required for 50% hydrolysis (C50),
which are summarized in Table 3.achieve similar saturation, more PtdIns(4,5)P2 was used for PZA,
which has a KD of 11 mM, than for PdZA, which has a KD of
0.7 mM. PZA was not displaced by Ins(1,4,5)P3 at concentrations
40-fold greater than the concentration of PtdIns(4,5)P2, using
vesicles with either 12.5 mM (Figure 4C2) or 25 mM PtdIns(4,5)
P2 (Figure 4C1). In contrast, half of the PdZA was displaced
from vesicles containing either 5 mM (Figure 4C3) or 12.5 mM (Fig-
ure 4C4) PtdIns(4,5)P2 at a concentration of Ins(1,4,5)P3 that was
less than half the PtdIns(4,5)P2 concentration, indicating that the
PLC d1 PH domain has a greater affinity for Ins(1,4,5)P3 than for
PtdIns(4,5)P2.
Effects of Mutations on the Binding of PZA to a
Membrane Bilayer
Four side chains from the A site interact with the bound
PtdIns(4,5)P2: K349, K355, W357, and Q412 (Figure 5A). The
two lysines (K349 and K355) form predicted salt bridges with
phosphate groups at positions 1 and 5 of the inositol ring. The
phosphate at the fourth position does not form any direct inter-
actions with the protein. At the C site, the bound PtdIns(4,5)P2
contacts more than eight residues. Both the 4- and 5-phosphate
interact with positively charged residues: phosphate-4 with
R360, H373, R378, and the main-chain nitrogen of A374. The
5-phosphate interacts with two positively charged side chains,
K348 and R407, with the latter stabilized by forming a salt bridge
with D351 (Figure 5A).
We changed amino acids identified as relevant in the cry-
stal structure to further test the hypothesis of two distinct sites
mediating binding to phospholipid bilayers (Figure 5A and Table
3). The prediction is that changing amino acids with positively
charged side chains in either the A or C site to neutral side1982 Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltdchains will reduce PtdIns(4,5)P2-dependent binding (Figure 5B1
and 2). The results of experiments examining PtdIns(4,5)P2-
dependent binding to LUVs were consistent with the prediction.
Figure 5B1 provides a comparison of wild-type protein with
proteins with mutations in the canonical site. Figure 5B2 pro-
vides comparisons of wild-type with mutations in the atypical
site and isoleucine 353, a residue in the b1/b2 loop that vacates
the canonical site on PtdIns(4,5)P2 binding. All mutants affected
PtdIns(4,5)P2-dependent binding, albeit to different extents.
Mutation of arginine 360 and lysine 348, which are in the ca-
nonical site, lysine 349 in the atypical site, and isoleucine 353
had the largest effects, with 20% or less of the mutated protein
bound at the highest concentration of PtdIns(4,5)P2 tested.
Mutating arginine 378 in the canonical site and lysine 355 in
the atypical site reduced binding but had less of an effect.
Aspartate, a negatively charged amino acid, in position 353
would be predicted to be either trapped in the positively
charged binding pocket for the inositol head group or be
repelled by the negatively charged membrane surface. In either
case, the affinity of [I353D]PZA for PtdIns(4,5)P2-containing
vesicles would be lower than for wild-type, as was observed.
Mutation of lysine 365, which is outside of the three elements,
had little or no effect on binding to LUVs (Figure 5B1).
We determined the affinity of diC4-PtdIns(4,5)P2 for the
ASAP1 PH domain and mutants using the change in tryptophan
fluorescence as an indicator of binding (Che et al., 2005). Based
on the hypothetical binding mechanism, mutating the cano-
nical site should reduce affinity for diC4-PtdIns(4,5)P2 whereas
mutation of residues in the atypical site should have no effect
because, in the absence of a bilayer, binding is not cooperative.
As predicted, mutating lysine 355 had no effect on bindingAll rights reserved
Table 2. PtdIns(4,5)P2-Dependent Binding of ASAP1 and PLC d1
PH Domains to LUVs
Protein
KD (mM)
No PtdSer +PtdSer
ASAP1 PH ND 7 ± 1
PLC d1 PH 1.3 ± 0.2 1.7 ± 0.2
PZA ND 11 ± 2
PdZA 0.96 ± 0.15 0.73 ± 0.2
Binding of recombinant proteins to LUVs either lacking the anionic lipid
PtdSer or containing 75 mM PtdSer and variable concentrations of
PtdIns(4,5)P2 was determined as described in Experimental Procedures.
Because the concentration of the PLC d1 recombinant proteins was
greater than the estimated KD, the data were fit to quadratic equations.
The values presented are from two experiments. The data for ASAP1
PH and PZA were fit to a hyperbolic function to estimate of the KD for
the PtdIns(4,5)P2-protein complexes. The values are the average ±
SEM for six experiments. ND, not determined.compared with wild-type protein, whereas mutation of arginine
360 reduced binding (Figure 4B).
The effect of the mutations on PtdIns(4,5)P2-dependent GAP
activity was examined (Table 3). In the absence of PtdSer and
PtdIns(4,5)P2, all proteins with mutations in the canonical site
had similar activity as wild-type ASAP1. Twomutants in the atyp-
ical site were examined. [K355N]PZA had activity that was
similar to wild-type. [K349N]PZA had half the activity of wild-
type. Mutation of isoleucine 353 to aspartate had more than a
10-fold reduction in activity. We determined the relative activity
of the mutants using LUVs containing PtdSer as the sole anionic
lipid. All mutants had reduced activity, with the largest effects
observed for proteins containing mutations in the atypical site
and isoleucine 353. We also determined the relative activity of
each of the mutants at saturating PtdSer and PtdIns(4,5)P2. Ef-
fects of mutations on activity correlated with effects on binding,
but in many cases were of greater magnitude. R360Q, K348N,
and K349N bound to 10% the extent of wild-type but had 1%–
4% the activity. [I353D]PZA bound to about 10% the extent of
wild-type PZA but had 0.25% the activity. In other cases, pro-
tein bound to the same extent as wild-type protein and had
similar activity, including K355N, R378Q, and R407N. We did
not detect an effect of mutating lysine 365, which is not in either
binding site, to asparagine (Table 3).
DISCUSSION
Wehave tested the hypothesis that the PH domain of ASAP1 has
cooperative canonical and atypical phosphoinositide-binding
sites (Figure 3). The cooperative binding of phospholipids pro-
vides ameans for efficient switching between active and inactive
forms of ASAP1.
The complex regulation of the Arf GAPs may have evolved to
provide site-specific function. Humans have five Arf isoforms,
each with multiple sites of action (D’Souza-Schorey and Chav-
rier, 2006; Donaldson, 2003; Donaldson et al., 2005; Gillingham
andMunro, 2007; Kahn et al., 2006). The Golgi in particular is en-
riched with several Arf isoforms, but the same isoforms function
outside of theGolgi apparatus (Kahn et al., 2006; Volpicelli-Daley
et al., 2005). The Arf GAPs are part of the regulatory machineryStructure 23, 1977–19that ensures site-specific function. Humans have 31 genes en-
coding Arf GAPs (Kahn et al., 2008). Multiple Arf GAPs may
engage each Arf isoform. If the Arf GAPs were not tightly
controlled, they could be recruited by the substrate Arf-GTP to
multiple sites. We propose that the Arf GAPs have recruitment
mechanisms that are independent of the activation mechanism.
ASAP1, for instance, appears to be recruited by its SH3 domains
and PXXP motifs to sites containing FAK, Src, and Crk (Liu et al.,
2002; Oda et al., 2003). Activity, on the other hand, is controlled
by the PH domain. Once targeted to a specificmembrane, coop-
erative binding of the activating lipid ligands ensures rapid and
complete switching between active and inactive forms of the
ASAP1. Because binding is cooperative, activation does not
require a large change in the concentration of the activating
ligand. Dependence on the coincidence of signals for both tar-
geting and enzymatic activity may restrict ASAP1 function
spatially and temporally.
Cooperative behavior is a means to efficiently switch a protein
between two states (Koshland and Hamadani, 2002; Whitty,
2008). Cooperative binding of PtdIns(3,4,5)P3 and Arf6-GTP to
the PH domain of Grp1 has been described (Malaby et al.,
2013), but not for two lipid ligands to a PH domain as far as we
are aware. ASAP1 has several possible sources of cooperative
behavior. First, the PH domain by itself displays cooperative
behavior as described here. Cooperative behavior may not
require conformational changes in the protein. With two binding
sites in a single protein that bind ligand spatially constrained to a
surface, there is reduced entropic cost for binding the second
site (Whitty, 2008). The difference in binding energy may result
in a sigmoidal dependence for ligand binding. Second, ASAP1
has three properties of cooperative enzymes (Koshland and
Hamadani, 2002). (1) Cooperative enzymes are composed of
multiple identical subunits. ASAP1 is a homodimer. (2) Ligand
binding in cooperative enzymes induces an intramolecular
conformational change in the subunit to which it binds. In this
study, we describe changes in the ASAP1 PH domain that occur
on PtdIns binding. (3) The conformational change in one subunit
affects the other subunit. Dimerization of ASAP1 is mediated by
the BAR domain. Modeling indicates that the BAR domain inter-
acts with the PH domain in trans (Jian et al., 2009), and therefore
may be able to transmit conformational information between
subunits. Cooperative behavior might also result from the hyster-
etic properties (Ainslie et al., 1972; Frieden, 1970) of ASAP1 (Luo
et al., 2007).
The mechanism we propose for the ASAP1 PH domain may
be generalized to a subset of other PH domains. Canonical
and atypical binding sites for phosphoinositides have been
described in PH domains. One site corresponds to the canon-
ical site found in proteins such as PLC-d, Akt, PDK, Btk, Grp1,
FAPP1, and TAPP1 (DiNitto and Lambright, 2006; Moravcevic
et al., 2012). The second site corresponds to the atypical site
first described in spectrin and found in proteins such as TIAM
and Slm1 (Hyvonen et al., 1995; Balla, 2005; DiNitto and Lam-
bright, 2006; Moravcevic et al., 2012; Scheffzek and Welti,
2012). Some evidence also supports the idea that the sites
are integrated. Simultaneous occupancy of the two sites has
been proposed for Slm1 (Anand et al., 2012; Gallego et al.,
2010). Akt has a patch of positive charge on its surface from
side chains of amino acids in loop b1/b2 and loop b5/b688, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1983
Table 3. Effect of PtdIns(4,5)P2 and PtdSer on Activity of ASAP1 with Mutations in the PH Domain
Protein Site
C50 (nM)
No PtdSer/no PtdIns(4,5)P2 +PtdSer/no PtdIns(4,5)P2 No PtdSer/+PtdIns(4,5)P2 +PtdSer/+PtdIns(4,5)P2
Wild-type 960 ± 350 63 ± 10 0.042 ± 0.007 0.044 ± 0.007
K365N Neither 860 ± 43 60 ± 5 0.033 ± 0.022
K348N Canonical 1,110 ± 260 170 ± 8 4.4 ± 1.8
R360Q Canonical 645 ± 31 110 ± 11 3.7 ± 0.8
R378Q Canonical 630 ± 10 145 ± 6 0.08 ± 0.03
R407Q Canonical 630 ± 60 92 ± 10 0.03 ± 0.01
K349N Atypical 2,180 ± 30 414 ± 20 1.0 ± 0.2
K355N Atypical 1,260 ± 62 270 ± 5 0.08 ± 0.02
I353D Loop >10,000 8,640 ± 560 11 ± 1
A protein comprising the PH, Arf GAP, and Ankyrin repeat domains of ASAP1 with the indicated mutations were titrated into GAP reactions containing
myrArf1$GTP and LUVs containing 75 mM PtdSer and 50 mM PtdIns(4,5)P2, as indicated. Reactions were stopped after 3 min and the fraction of GTP
bound to Arf that was hydrolyzed was determined. GTP hydrolysis was plotted against protein concentration, from which the concentration of protein
necessary to achieve 50% hydrolysis was estimated (C50). Estimates from three experiments with SD are provided for the wild-type PZA. The average
from two experiments and the range are shown for the mutants.(Bellacosa et al., 1998; Milburn et al., 2003; Thomas et al.,
2002). These charged side chains could bind to anionic lipid
head groups, and are in a position similar to that of the atypical
site described in spectrin. A mutant Akt with one of the charged
residues in this patch neutralized has less activity than wild-
type Akt, consistent with the idea of an A site in Akt (Huang
et al., 2011). Also, the dependence of Akt activity on PtdSer
may be related (Huang et al., 2011). The specific interactions
between binding sites will likely differ among PH domains.
Furthermore, the hypothetical model likely applies to a subset
of PH domains. Indeed, in this study we report differences be-
tween the ASAP1 and PLCd1 PH domains.
The integration of structural elements involved in membrane
binding has been reported for other phospholipid-binding
domains. The PX domain of p47phox has two lipid-binding
sites, one for PtdIns(3,4)P2 and the other for phosphatidic
acid, separated by a hydrophobic ridge thought to insert
into the membrane. Phospholipid binding is cooperative, as
observed with ASAP1 (Karathanassis et al., 2002). Similarly,
the C2 domain of PKCa binds cooperatively to PtdIns(4,5)P2
and PtdSer. Also similar to ASAP1, Ins(1,4,5)P3 binds with
lower affinity than does PtdIns(4,5)P2 in a bilayer (Guerrero-
Valero et al., 2009), which is different from what was reported
for the PH domain of PLC d1 (Lemmon et al., 1995). The multi-
contact protein-phospholipid bilayer interface may be a com-
mon feature of peripheral membrane proteins involved in
signaling.
Association with a planar membrane likely has additional con-
sequences for ASAP1 interaction with its substrate Arf-GTP. For
some mutants we examined, the effect on activity was dispro-
portionate to the effect on binding, e.g. I353, K349, and R360.
The disproportion could indicate additional conformational
changes in the PH domain that occur on binding a planar sur-
face. diC4-PtdIns(4,5)P2 can bind but increases activity by only
2- to 4-fold, even when present at saturating concentrations
(Che et al., 2005). Thus, the active conformation would not be
apparent with dibutyryl PtdIns(4,5)P2 bound in the crystal.
Our crystal structure revealed plasticity in the canonical
PtdIns(4,5)P2-binding site, which is able to accommodate1984 Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltdthe inositol phosphate ring in two orientations. This plasticity
could account for the promiscuity for phosphoinositide iso-
forms that has been observed with ASAP1, which is similar
to many PH domains. The PH domains that bind inositol lipids
have been broadly classified into four groups (Maffucci and
Falasca, 2001). From our biochemical and structural charac-
terizations, the ASAP1 PH domain may belong to the group
2 PH domains that bind PtdIns(4,5)P2, PtdIns(3,4,5)P3, and
others. A detailed comparison of the canonical PtdIns-binding
sites for various PH domains shows a high similarity in the
molecular interactions (Figure S3B), mostly involving charged
interactions. However, bound PtdIns molecules display con-
siderable flexibility in their interactions with their respective
PH domains, e.g. symmetric rotation among PtdIns phos-
phates interacting with different residues in the binding
pocket. Our observation of ASAP1 PH domain binding to
diC4 PtdIns(4,5)P2 in two different configurations further sup-
ports this point and suggests that the binding pocket does not
discriminate the configuration of the six-membered inositol
ring.
There are numerous examples of phosphoinositide binding to
the atypical binding site in PH domains (Figure S3C). In all these
cases, the PH domain binds phospholipid between b1/b2 and
b5/b6 loops. Superposition of ASAP1 PH domain to those with
bound ligand in the atypical site shows that ASAP1 PH domain
possesses the atypical site (Figure S3C).
In summary, we have tested the hypothesis that the PH
domain of ASAP1 has two cooperative phospholipid-binding
sites that control GAP activity, and we propose that this mecha-
nism is combined with targeting mediated by coincident signals
to spatially and temporally restrict ASAP1 function.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Bacterial expression vectors for His10-[325–724]ASAP1 (i.e. ASAP1 PZA),
His10-[325–451]ASAP1 (i.e. ASAP1 PH), PLCd-PH, PdZA, and myristoylated
Arf1 (myrArf1) were described by Brown et al. (1998), Che et al. (2005), and
Randazzo et al. (1995). [339–451]ASAP1 (used for NMR studies) was prepared
as described for other ASAP1 PH domain constructs. Mutations in ASAP1All rights reserved
Figure 4. Affinity of PH Domains for the
Inositol Phosphate Head Group and Soluble
Forms of PtdIns
(A) Ins(1,4,5)P3 binding to the PH domain of ASAP1
(1) and PLC d1 (2) determined by ITC. A total of 13
injections of 3 ml of Ins(1,4,5)P3 (3mM)were titrated
into the ASAP1 PH domain (0.02 mM). Similarly, a
total of 13 injections of 3 ml of Ins(1,4,5)P3 (0.1 mM)
were titrated into the PLCd1 PH domain protein
(0.01 mM). The background heat of dilution
generated during the experiment was subtracted
in each experiment, which was determined by
titrating the same amount of Ins(1,4,5)P3 into PBS
alone.
(B) DiC4-PtdIns(4,5)P2 binding to the PH domain
of ASAP1. Tryptophan fluorescence of the
ASAP1 PH domain with the indicated amino acid
changes in the presence of the indicated con-
centration of diC4-Ptdns(4,5)P2 was measured.
Fluorescence normalized to fluorescence in
the absence of diC4-PtdIns(4,5)P2 is plotted
against diC4-PtdIns(4,5)P2 concentration. WT,
wild-type.
(C) Displacement of PZA and PdZA from PtdSer/
PtdIns(4,5)P2-containing vesicles by Ins(1,4,5)P3.
PZA and PdZA were incubated with LUVs
containing 15% PtdSer and the indicated con-
centrations of PtdIns(4,5)P2 and Ins(1,4,5)P3. The
fraction of total protein in the incubation that ad-
sorbed to the LUVs is plotted against Ins(1,4,5)P3
concentration.PZA and ASAP1 PH were generated using the QuikChange II site-directed
mutagenesis kit (Agilent Technologies). ASAP1 PZA wild-type andmutant pro-
teins, PdZA, as well as ASAP1 PH wild-type and mutant proteins were pre-
pared as previously described (Jian et al., 2009). PLCd-PH, corresponding
to residues 11–140 of rat PLC-d1, was expressed in bacteria and purified using
cation-exchange column HiTrapSP (GE Healthcare) and size-exclusion chro-
matography as previously described (Lemmon et al., 1995). Bacterial expres-
sion and purification of myrArf1 has been previously described (Chen et al.,
2012).
Preparation of LUVs
LUVs, prepared by extrusion with lipids purchased from Avanti Polar Lipids
as described previously (Jian et al., 2009; Nie et al., 2006), contained molarStructure 23, 1977–1988, November 3, 2015ratios of 40% phosphatidylcholine (PtdCho),
25% phosphatidylethanolamine (PtdEtn), 15%
phosphatidylserine (PtdSer), 10% PtdIns(4,5)P2,
and 10% cholesterol (+PtdSer/+PtdIns(4,5)P2
LUV), or 40% PtdCho, 40% PtdEtn, 10%
PtdIns(4,5)P2, and 10% cholesterol (no
PtdSer/+PtdIns(4,5)P2 LUV), or 40% PtdCho,
25% PtdEtn, 15% PtdSer, 10% phosphatidylino-
sitol (PtdIns), and 10% cholesterol (+PtdSer/no
PtdIns(4,5)P2 LUV), or 40% PtdCho, 40% PtdEtn,
10% PtdIns, and 10% cholesterol (no PtdSer/no
PtdIns(4,5)P2 LUV). For the PtdIns(4,5)P2 titration
experiments, PtdIns(4,5)P2 amount varied from
0% to 10%, and the amount of phosphoinositide
was changed to keep PtdIns plus PtdIns(4,5)P2
at 10%.
diC4-PtdIns(4,5)P2-Induced Change in PH
Domain Tryptophan Fluorescence
The binding of diC4-PtdIns(4,5)P2 to the PH
domain of ASAP1 wild-type or mutants increasedtryptophan fluorescence. diC4-PtdIns(4,5)P2 was mixed with 1 mM of ASAP1
PH wild-type or mutants in a buffer containing 20 mM HEPES (pH 7.4)
and 100 mM NaCl. Tryptophan fluorescence spectra were obtained using a
FluoroMax-3 spectrophotometer (Jobin Yvon Horiba). The excitation wave-
length was 280 nm, and the emission spectra from 310 to 450 nm were
collected.
Lipid-Binding Assay
The assay for protein binding to lipid vesicles is described by Jian et al. (2009)
and Nie et al. (2006). One mM for PZA wild-type, mutants, or PdZA or 3 mM
ASAP1 PH or PLCd-PH were incubated with sucrose-loaded LUVs containing
500 mM total phospholipids. The LUVs were precipitated by ultracentrifuga-
tion, and associated proteins were separated by SDS-PAGE and visualizedª2015 Elsevier Ltd All rights reserved 1985
Figure 5. Mutational Analysis of Phospho-
lipid-Binding Sites
(A) Stereo diagram showing detailed interactions
of the two bound PtdIns(4,5)P2 with residues in
the binding sites. Bound PtdIns(4,5)P2 molecules
are shown as stick models with carbon atoms in
black, oxygen in red, and phosphor in orange.
Amino acid residues taking part in interactions
with PtdIns(4,5)P2 are also displayed as stick
models with carbons in purple, nitrogen in dark
blue, and oxygen in red. The two lipid-binding
sites are also labeled as A site and C site,
respectively.
(B) Binding to vesicles. (1) Mutations in canonical
site. (2) Mutations in the atypical site and b1/b2
loop. Wild-type (WT) PZA and PZA with the indi-
cated changes in amino acids were incubated with
LUVs containing 15% PtdSer and the indicated
concentration of PtdIns(4,5)P2.by Coomassie blue staining. The signal was quantified by densitometry using
ImageJ software.
GAP Assays
ASAP1-induced conversion of myrArf1$GTP to myrArf1$GDP was determined
as described previously (Kam et al., 2000; Randazzo and Kahn, 1994; Ran-
dazzo et al., 2001, 2013). ASAP1 PZA was titrated into the reaction containing
myrArf1$GTP as the substrate. The amount of ASAP1 required to hydrolyze
50% of the Arf bound GTP in 3 min (C50) is presented.
Isothermal Titration Calorimetry
ITC experiments were performed using an ITC200 calorimeter (Malvern). All
samples were prepared in PBS. Ins(1,4,5)P3 was titrated into protein solutions
at 25C and the background heat of dilution was subtracted in each experi-
ment. Data were fitted using a one-site model from Origin7 software (Origin-
Lab). The averaged binding parameters were obtained from three independent
experiments.
Crystallization Experiments of Apo PH Domain and Its Complex with
Dibutyryl PtdIns(4,5)P2
Initial crystallization was performed utilizing the high-throughput crystallization
screening service offered by the Hauptman-Woodward Medical Research1986 Structure 23, 1977–1988, November 3, 2015 ª2015 Elsevier Ltd All rights reservedInstitute (www.hwi.buffalo.edu). ASAP1 PH
domain (400 mM in 20 mM Tris-HCl [pH 7.4],
150 mM NaCl, and 0.01% NaN3) was crystallized
for diffraction using a hanging-drop vapor diffusion
setup with a one-to-one admixture of the protein
and awell solution consisting of 100mMNa2HPO4,
100 mM Tris (pH 8.0) and 48% PEG400 (v/v) at
23C. ASAP1 PH domain in the presence of dibu-
tyryl PtdIns(4,5)P2 (400 mM ASAP1 PH domain,
1 mM diC4-PtdIns(4,5)P2, 20 mM Tris [pH 7.4],
150 mM NaCl, and 0.01% NaN3) was crystallized
at 21C by mixing the protein with equilibration so-
lution (0.1 M HEPES [pH 7.5], 15% PEG3350) in a
one-to-one ratio.
X-Ray Diffraction Experiments
Unliganded-ASAP1 PH domain crystals were
flash-cooled directly in liquid nitrogen prior to
X-ray diffraction. The PH domain crystals dif-
fracted X-rays to 1.8 A˚ resolution at the insertion
device magnet of SER-CAT at the Advanced
Photon Source, Argonne National Laboratory.
Diffraction images were recorded on a Marw225
CCD detector. Crystals of PH domain/diC4-
PtdIns(4,5)P2 complex were cryoprotected by a quick soak in a cryoprotec-
tant solution made of 7 ml of crystallization well solution supplemented with
3 ml of 50% PEG3350 followed by flash-cooling to 100 K of a nitrogen
stream. A diffraction dataset was collected using X-rays from an in-house
Rigaku X-ray generator operating at 100 mA and 50 kV and a Mar345 imag-
ing plate scanner. Diffraction images from both types of crystals were pro-
cessed with using the HKL2000 program suite (Otwinowski and Minor, 1997)
(Table 1).
Structure Determination and Refinement
The crystal structure of unliganded-ASAP1 PH domain was determined by
the molecular replacement method using coordinates from the solution
structure of the PH domain of ASAP1 (PDB: 2DA0) (not yet published) as
phasing template using the program Molrep (Vagin and Teplyakov, 2000).
Subsequent refinement was performed with Refmac in the CCP4 package
(CCP4, 1994) and molecular modeling was carried out in Coot (Emsley and
Cowtan, 2004).
The unliganded PH domain structure was used as the search model for
molecular replacement program Molrep to solve the structure of the PH
domain/diC4-PtdIns(4,5)P2 complex. Subsequent refinement was performed
with Refmac in the CCP4 package, and molecular modeling was carried out
in Coot.
Equations
Equations based on the scheme presented in Figure 4 were derived as
described by Cha (1968).
Assuming a1 = a2, the amount of PH domain-containing protein bound to
vesicles is:
PH bound=
ðPtdInsP2Þ2
a,K1,K2
+
ðPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
1+
ðPtdInsP2Þ2
a,K1,K2
+
ðPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
(Equation 1)
Further assuming that Vmax1 = Vmax2 and KM1 =KM2, the initial rate is related
to phospholipid concentration by:vi =
Vmax,Arf,GTP
KM
,
"
ðPtdInsP2Þ2
a,K1,K2
+
ðPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
#
1+
ðPtdInsP2Þ2
a,K1,K2
+
ðPSPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
+
"
ðPtdInsP2Þ2
a,K1,K2
+
ðPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
#
,
Arf,GTP
KM
(Equation 2)Assuming Arf,GTP  KM activity determined as described by Randazzo
et al. (2013) can be related to phospholipid concentration by:Activity=
Vmax,Arf,GTP
KM
,
2
4
ðPtdInsP2Þ2
a,K1,K2
+
ðPSPtdSerÞ,ðPtdInsP2Þ
a,KPtdSer,K2
1+
ðPtdInsP2Þ2
a,K1,K2
+
ðPtdSerÞ,ðPtdInsP2Þ
a,KPSPtdSer,K2
3
5
(Equation 3)
In Equations 1 and 3, if PtdSer >> PtdInsP2, the square term of PtdInsP2 is
negligible and the relationship of binding or activity to PtdInsP2 concentration
is hyperbolic.
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